WO2007084895A3 - Regulation de jonctions communicantes a l’aide de peptides - Google Patents

Regulation de jonctions communicantes a l’aide de peptides Download PDF

Info

Publication number
WO2007084895A3
WO2007084895A3 PCT/US2007/060584 US2007060584W WO2007084895A3 WO 2007084895 A3 WO2007084895 A3 WO 2007084895A3 US 2007060584 W US2007060584 W US 2007060584W WO 2007084895 A3 WO2007084895 A3 WO 2007084895A3
Authority
WO
WIPO (PCT)
Prior art keywords
cx43ct
peptide
fifteen
formula
gap junctions
Prior art date
Application number
PCT/US2007/060584
Other languages
English (en)
Other versions
WO2007084895A2 (fr
Inventor
Mario Delmar
Steven M Taffet
Original Assignee
Univ New York State Res Found
Mario Delmar
Steven M Taffet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found, Mario Delmar, Steven M Taffet filed Critical Univ New York State Res Found
Priority to EP07718080A priority Critical patent/EP1978988A4/fr
Publication of WO2007084895A2 publication Critical patent/WO2007084895A2/fr
Priority to US12/172,355 priority patent/US20090075291A1/en
Publication of WO2007084895A3 publication Critical patent/WO2007084895A3/fr
Priority to US13/279,703 priority patent/US20120101255A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne des protéines et des polypeptides qui (i) répondent à la formule A-[W-A]n dans laquelle A représente un peptide répondant à la formule XXXXRXPXXXX, dans laquelle X représente un acide aminé, R représente une arginine et P une proline ; W représente un agent de liaison ; et n représente un quelconque nombre compris entre 1 et 5 ; ou qui (ii) répondent essentiellement à la formule XnRXPX3n dans laquelle chaque X représente un quelconque acide aminé, R représente une arginine, P représente une proline, n est un quelconque nombre compris entre zéro et quinze, m est un quelconque nombre compris entre zéro et quinze, la somme de n et m étant comprise entre dix et quinze. L’invention concerne également des procédés dans lesquels ces protéines et polypeptides servent à : cribler des composés modulant Cx43CT, mesurer l’affinité de liaison à Cx43CT d’un composé se liant à Cx43CT et à identifier l’emplacement d’un domaine de liaison à RXP de Cx43CT.
PCT/US2007/060584 2006-01-13 2007-01-16 Regulation de jonctions communicantes a l’aide de peptides WO2007084895A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP07718080A EP1978988A4 (fr) 2006-01-13 2007-01-16 Regulation de jonctions communicantes a l aide de peptides
US12/172,355 US20090075291A1 (en) 2006-01-13 2008-07-14 Peptide-based regulation of gap junctions
US13/279,703 US20120101255A1 (en) 2006-01-13 2011-10-24 Peptide-based regulation of gap junctions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75888606P 2006-01-13 2006-01-13
US60/758,886 2006-01-13

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/172,355 Continuation-In-Part US20090075291A1 (en) 2006-01-13 2008-07-14 Peptide-based regulation of gap junctions

Publications (2)

Publication Number Publication Date
WO2007084895A2 WO2007084895A2 (fr) 2007-07-26
WO2007084895A3 true WO2007084895A3 (fr) 2008-08-14

Family

ID=38288369

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/060584 WO2007084895A2 (fr) 2006-01-13 2007-01-16 Regulation de jonctions communicantes a l’aide de peptides

Country Status (2)

Country Link
EP (1) EP1978988A4 (fr)
WO (1) WO2007084895A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090075291A1 (en) * 2006-01-13 2009-03-19 The Research Foundation Of State University Of New York Peptide-based regulation of gap junctions
WO2009029991A1 (fr) 2007-09-07 2009-03-12 Meat & Livestock Australia Limited Agents présentant une activité angiogénique et de guérison de plaies
EP2260859A1 (fr) * 2009-06-12 2010-12-15 Zealand Pharma A/S Composés agissant en tant que modulateurs de jonction communicante de peptide et leurs utilisations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000026315A (ja) * 1998-07-09 2000-01-25 Dai Ichi Seiyaku Co Ltd カルシウムチャンネル活性化剤の評価方法
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
WO2005079849A2 (fr) * 2004-02-25 2005-09-01 Zgene A/S Composes pour la traitement ameliore du cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009012224A2 (fr) * 2007-07-13 2009-01-22 The Research Foundation Of State University Of New York Régulation à base de peptides à jonction lacunaire

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
JP2000026315A (ja) * 1998-07-09 2000-01-25 Dai Ichi Seiyaku Co Ltd カルシウムチャンネル活性化剤の評価方法
WO2005079849A2 (fr) * 2004-02-25 2005-09-01 Zgene A/S Composes pour la traitement ameliore du cancer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE PIR [online] MORI ET AL., XP008120453, Database accession no. (I46480) *
DATABASE PIR [online] MORI ET AL., XP008120454, Database accession no. (T18630) *
DUFFY ET AL.: "Regulation of connexin43 protein complexes by intracellular acidification", CIRCULATION RESEARCH, vol. 94, February 2004 (2004-02-01), pages 215 - 222, XP008128904 *
See also references of EP1978988A4 *

Also Published As

Publication number Publication date
WO2007084895A2 (fr) 2007-07-26
EP1978988A4 (fr) 2009-11-04
EP1978988A2 (fr) 2008-10-15

Similar Documents

Publication Publication Date Title
Zhang et al. Complete disulfide bond assignment of a recombinant immunoglobulin G4 monoclonal antibody
NO20090875L (no) Fusjonspeptid for inhibenng av interaksjon mellom neuronal NMDA-reseptor og NMDAR-mteragerende proteiner
ATE298763T1 (de) Integrinbindende peptidderivate
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
BRPI0809366B8 (pt) polipeptídeo substancialmente alfa-helicoidal, método para fabricação do mesmo, aminoácido e composição farmacêutica
DE602005008996D1 (de) Radiofluorierte peptide
EA200802059A1 (ru) Циклические конструкты натрийуретических пептидов
ATE489623T1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
WO2012078313A3 (fr) Banques peptidiques gb 1 et composés associés, et leurs procédés de criblage
DE60100506D1 (de) 1,3-dihydro-2h-indol-2-on derivate und deren verwendung als liganden der arginin-vasopressin rezeptoren v1b oder v1b und v1a
WO2007084895A3 (fr) Regulation de jonctions communicantes a l’aide de peptides
Gao et al. Examination of novel non-phosphorus-containing phosphotyrosyl mimetics against protein-tyrosine phosphatase-1B and demonstration of differential affinities toward Grb2 SH2 domains
WO2007000672A3 (fr) Antagonistes peptidiques des complexes semaphorines/neuropilines de classe iii
ATE484749T1 (de) Von anti-trichinella-antikörpern erkannte polypeptide und ihre verwendung
WO2007144512A3 (fr) Derivés diazeniumdiolates, leur procédé de préparation, leurs compositions pharmaceutiques et leur utilisation dans le domaine de l ' hypertension et des pathologies cardiovasculaires
WO2009012224A3 (fr) Régulation à base de peptides à jonction lacunaire
Xiao et al. Identification and quantification of degradations in the Asp–Asp motifs of a recombinant monoclonal antibody
WO2006103101A3 (fr) Moyens pour l'inhibition d'anticorps anti-recepteurs $g(b)1 adrenergiques
WO2011137389A3 (fr) Compositions et procédés destinés à détecter et/ou à mesurer de manière fiable la quantité d'une protéine modifiée cible dans un échantillon
WO2007117665A3 (fr) Analyse par derivation optimisee d'aminoacides et peptides
Inguimbert et al. N-[2-(Indan-1-yl)-3-mercapto-propionyl] amino acids as highly potent inhibitors of the three vasopeptidases (NEP, ACE, ECE): in vitro and in vivo activities
WO2000073326A3 (fr) Inhibiteurs de peptide cyclique non phosphore stable a la redox permettant une liaison d'un domaine sh2 a une proteine cible, leur conjugues, les compositions associees, les procedes de synthese ainsi que leur utilisation
WO2006078431A3 (fr) Compositions et procedes associes a des vecteurs retroviraux modifies pour une integration restreinte specifique au site
WO2007095378A3 (fr) Marquage de masse pour l'analyse quantitative de biomolécules au moyen de phénylisocyanate étiqueté 13c
Chen et al. Cyclic peptide-based potent and selective SIRT1/2 dual inhibitors harboring Nε-thioacetyl-lysine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007718080

Country of ref document: EP